BET bromodomain inhibitor

CAS No. 1505453-59-7

BET bromodomain inhibitor( MDK3597 | MDK-3597 | MDK 3597 | BET bromodomain inhibitor )

Catalog No. M12098 CAS No. 1505453-59-7

It is a BET bromodomain inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 76 In Stock
2MG 43 In Stock
5MG 69 In Stock
10MG 117 In Stock
25MG 198 In Stock
50MG 272 In Stock
100MG 431 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BET bromodomain inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    It is a BET bromodomain inhibitor.
  • Description
    It is a BET bromodomain inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MDK3597 | MDK-3597 | MDK 3597 | BET bromodomain inhibitor
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    BET bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1505453-59-7
  • Formula Weight
    400.26
  • Molecular Formula
    C20H15Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(N)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C3=CC(Cl)=CC=C3C4=C1ON=C4C
  • Chemical Name
    (S)-2-[8-Chloro-6-(4-chloro-phenyl)-1-methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xiao Y, et al. Rheumatology (Oxford). 2015 Aug 3
molnova catalog
related products
  • SRX3177

    SRX3177 is a novel and potent inhibitor of BRD4, PI3K and CDK.SRX3177 has potential anticancer activity.

  • BRM/BRG1 ATP Inhibit...

    BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.

  • BRD7-IN-1

    BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 via linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively .